← Back
$RAPP All transactions

Rapport Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

5,000

Price

$0

Filed

Dec 1

Insider

Name

Gault Cheryl

Title

Chief Operating Officer

CIK

0001839046

Roles

Officer

Transaction Details

Transaction Date

2025-11-26

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

105,407

Footnotes

These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2024. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. | 25% of the shares underlying this option vested and became exercisable on August 7, 2024, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Filing Info

Accession No.

0001193125-25-303910

Form Type

4

Issuer CIK

0002012593

Gault Cheryl's History

Date Ticker Type Value
2026-03-30 RAPP $201K
2026-03-30 RAPP $81K
2026-02-02 RAPP A $0
2025-11-26 RAPP M $9K
2025-11-26 RAPP $150K
2025-11-26 RAPP M $0
2025-09-08 RAPP M $9K
2025-09-08 RAPP $192K
2025-09-08 RAPP M $0

Other Insiders at RAPP (90d)

Insider Bought Sold Last
Ignelzi Troy A.
Chief Financial Officer
2026-02-02
Ceesay Abraham
Chief Executive Officer
2026-02-02
Third Rock Ventures V, L.P. $17.2M 2026-04-17
Sevigny Jeffrey
Chief Medical Officer
2026-02-02
Gault Cheryl
Chief Operating Officer
$282K 2026-03-30
Bredt David
Chief Scientific Officer
2026-02-02
Yeleswaram Krishnaswamy
Chief Development Officer
$1.8M 2026-04-17